Modern Hormone Replacement Therapy Not Linked to Heart Disease Risk in New Study

A new study suggests that contemporary hormone replacement therapy (HRT) does not raise the risk of heart attacks, strokes, blood clots, or death in women aged 45 to 59. The research, conducted in Israel, followed more than 52,000 participants over an extended period to assess long-term health outcomes.

The findings, which are preliminary and independent, will be shared at the American Heart Association’s Scientific Sessions 2026 in Chicago. The conference runs from November 6 to 9, 2026, and will feature presentations on advances in cardiovascular health research.

Researchers emphasize that the study does not claim HRT is universally safe for all women but highlights that modern formulations may differ significantly from older versions previously linked to cardiovascular risks. The results add to the ongoing debate about the safety and efficacy of hormone therapy for menopausal symptoms.

Based on reporting from Medical Xpress (Cancer).

Source: Medical Xpress (Cancer). This article was drafted by AI from that reporting and reviewed by an automated accuracy check before publishing.